Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

A Nasally Applied Cellulose Powder in Seasonal Allergic Rhinitis in Adults with Grass Pollen Allergy: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study

Artikel i vetenskaplig tidskrift
Författare Nils Åberg
S. T. Ospanova
N. P. Nikitin
J. Emberlin
Åslög Dahl
Publicerad i International archives of allergy and immunology
Volym 163
Nummer/häfte 4
Sidor 313-318
ISSN 1018-2438
Publiceringsår 2014
Publicerad vid Institutionen för biologi och miljövetenskap
Institutionen för kliniska vetenskaper, sektionen för kvinnors och barns hälsa, Avdelningen för pediatrik
Sidor 313-318
Språk en
Länkar dx.doi.org/10.1159/000360734
Ämnesord Allergic rhinitis, Barrier protection, Cellulose powder, Clinical trial, Grass pollen, SYMPTOMS, RHINOCONJUNCTIVITIS, TRIAL, METAANALYSIS, ADOLESCENTS, PREVALENCE, EFFICACY, CHILDREN, DISEASE, ECZEMA, Allergy, Immunology, ALLERGY, IMMUNOLOGY
Ämneskategorier Klinisk medicin

Sammanfattning

Background: A nasally applied cellulose powder is increasingly used in many countries as a remedy for allergic rhinitis. In 2009, a 4-week study in birch pollen-allergic children showed a reduction in nasal symptoms. The best effect occurred on days with lower pollen counts. The present study in grass pollen-allergic adults used the same basic design. Methods: In May 2013, a double-blind, placebo-controlled study was conducted in 108 patients with allergic rhinitis due to grass pollen (18-40 years of age). SMS on mobile phones were used as reminders of treatment and reporting of symptom scores. Results: We found significant reductions in severity scores for sneezing, runny nose, stuffy nose and symptoms from eyes and lower airways, both separately and together (all p < 0.001). Reflective opinion of effect and guess on treatment at follow-up visits (both p < 0.001) confirmed a high efficacy. No clinically significant adverse effects were reported. Conclusions: The product provided significant protection against all seasonal allergic rhinitis symptoms from both upper and lower airways during the grass pollen season in an adult population. The magnitude and scope of efficacy support the use of the product as an early choice in the treatment of allergic rhinitis. (C) 2014 S. Karger AG, Basel ERG N, 1990, ACTA PAEDIATRICA SCANDINAVICA, V79, P206

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?